Osteoporosis drugs in real-world clinical practice: An analysis of persistence

Aging Clinical and Experimental Research

Volumn 25, Issue 1 SUPPL., 2013, Pages

  Iolascon, Giovanni ^a   Gimigliano, Francesca ^a   Orlando, Valentina ^b   Capaldo, Annarita ^a   Di Somma, Carolina ^c   Menditto, Enrica ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

Database; Drug utilization; Osteoporosis; Persistence

Indexed keywords

ALENDRONIC ACID; CALCIUM; IBANDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; VITAMIN D;

ADULT; AGED; CLINICAL PRACTICE; COHORT ANALYSIS; CONFERENCE PAPER; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRESCRIPTION; REFERENCE DATABASE; RETROSPECTIVE STUDY;

ADULT; AGED; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DRUG SUBSTITUTION; ETIDRONIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RETROSPECTIVE STUDIES; THIOPHENES;

EID: 84886830195     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-013-0127-5     Document Type: Conference Paper

References (15)

1. Piscitelli P, Iolascon G, Gimigliano F, SIOMMMS study group, CERSUM research group et al (2007) Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int 18:211-219
2. Kanis JA, Burlet N, Cooper C, European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) et al (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399-428
3. Cramer JA, Roy A, Burrell A et al (2008) Medication compliance and persistence: terminology and definitions. Value Health 11:44-47
4. Wade SW et al (2012) Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan. Bone 50:870-875
5. Imaz I, Zegarra P, Gonzalez-Enriquez J, Rubio B, Alcazar R, Amate JM (2010) Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 21:1943-1951
6. Yood RA, Emani S, Reed JI et al (2003) Compliance with pharmacologic therapy for osteoporosis. Osteoporos Int 14:965-968
7. Rossini M, Bianchi G, Di Munno O, Treatment of Osteoporosis in clinical Practice (TOP) Study Group et al (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914-921
8. Baio G, Barbagallo M, D'Avola G, Di Luccio A, Di Tanna G, Falaschi P, Iolascon G, Malavolta N, Robbiati F, Ulivieri F (2011) Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis. Expert Opin Pharmacother 12(2):257-268 (Review)
9. De Berardis G, D'Ettorre A, Graziano G et al (2012) The burden of hospitalization related to diabetes mellitus: a population-based study. Nutr Metab Cardiovasc Dis 22(7):605-612
10. Gallagher AM, Rietbrock S, Olson M, van Staa TP (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 23:1569-1575
11. Huybrechts KF, Ishak KJ, Caro JJ (2006) Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 38:922-928
12. Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Jt Surg Am 90(10):2142-2148
13. Siris ES, Selby PL, Saag KG, Borgstrom F, Herings RM, Silverman SL (2009) Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med 122:S3-S13
14. Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ (2007) Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 82:1493-1501
15. Tafaro L, Nati G, Leoni E, Baldini R, Cattaruzza MS, Mei M, Falaschi P (2013) Adherence to anti osteoporotic therapies: role and determinants of "spot therapy". Osteoporos Int 24(8):2319-2323. doi: 10.1007/s00198-013-2283-zEpub2013Feb12